Molecular cancer therapy: can our expectation be MET?

C Migliore, S Giordano - European Journal of Cancer, 2008 - Elsevier
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

Intragenic mutations in thyroid cancer

M Sobrinho-Simoes, V Maximo, AS Rocha… - … and metabolism clinics …, 2008 - Elsevier
The close genotype-phenotype relationship that characterizes thyroid oncology stimulated
the authors to address this article by using a mixed, genetic and phenotypic approach. As …

Recent advances in thyroid cancer. In brief

EG Grubbs, TA Rich, G Li… - Current problems …, 2008 - pubmed.ncbi.nlm.nih.gov

Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23. 1-p22 by high-density single-nucleotide polymorphism genome-wide …

BM Cavaco, PF Batista, LG Sobrinho… - The Journal of Clinical …, 2008 - academic.oup.com
Context: Familial nonmedullary thyroid carcinoma (FNMTC) accounts for approximately 5%
of all thyroid tumors. Genetic mapping studies have identified four different chromosomal …

Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS …

BM Cavaco, PF Batista, C Martins… - Endocrine-related …, 2008 - erc.bioscientifica.com
Rac1, a Rho GTPase, modulates diverse cellular processes and is hyperactive in some
cancers. Estrogen receptor-alpha (ERα) in concert with intracellular signaling pathways …

[PDF][PDF] The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione-PPARg agonists

V Costa, D Foti, F Paonessa, E Chiefari, L Palaia… - Endocrine-Related …, 2008 - Citeseer
The peroxisome proliferator-activated receptor-g (PPARg) is a member of the nuclear
hormone receptor superfamily. Ligand activation of PPARg is associated with differentiation …

Induction of sodium iodide symporter gene and molecular characterisation of HNF3β/FoxA2, TTF-1 and C/EBPβ in thyroid carcinoma cells

T Akagi, QT Luong, D Gui, J Said, J Selektar… - British journal of …, 2008 - nature.com
Thyroid carcinoma cells often do not express thyroid-specific genes including sodium iodide
symporter (NIS), thyroperoxidase (TPO), thyroglobulin (TG), and thyrotropin-stimulating …

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

Y Shi, M Zou, EY Baitei, AS Alzahrani, RS Parhar… - Cancer gene …, 2008 - nature.com
Anaplastic thyroid carcinoma is the most aggressive type of thyroid malignancies.
Previously, we demonstrated that tumorigenicity of anaplastic thyroid carcinoma cell line …

[PDF][PDF] 같은엽에동시발생한갑상선유두상암과여포상암2 예

서경원, 최재영, 김정훈 - 고신대학교의과대학학술지, 2008 - lib.kosinmed.or.kr
―――Abstract―――――――――――――――――――――――――――――――――――
―――――We report two rare cases of concurrent papillary thyroid carcinoma and follicular …

[图书][B] Molecular mechanisms of human thyroid tumorigenesis

EL Ball - 2008 - search.proquest.com
Thyroid cancer is the commonest endocrine malignancy. Several of the initiating genetic
events in thyroid tumorigenesis have been identified, although the exact molecular …